WHO recommends Phase III trial of Ebola vaccine against Bundibugyo virus
The recommendation comes as researchers develop vaccines and treatments for the ongoing outbreak in the Democratic Republic of the Congo (DRC). The post WHO recommends Phase III trial of Ebola vaccine against Bundibugyo virus appeared first on Premium Times Nigeria .
The World Health Organization has recommended a Phase III trial of an Ebola vaccine against the Bundibugyo virus. This comes as researchers work on vaccines and treatments for the ongoing Ebola outbreak in the Democratic Republic of the Congo.
The current outbreak in the DRC is primarily caused by the Bundibugyo virus, a type of Ebola virus. According to The Indian Express, the outbreak is on track to become the deadliest on record, with the WHO warning it could eclipse the 2014-2016 outbreak that killed at least 11,000 people.
The Bundibugyo virus was first identified in 2007 in western Uganda, near the border with the DRC, resulting in 116 cases and 39 deaths. The Indian Express also notes that each Ebola virus species is 30-40% divergent from one another.
Brief written by urgent.news from Premium Times, The Indian Express — 2 reports on this story. Machine-written — it may contain errors, so check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- What makes controlling Ebola virus challenging indianexpress.com
